Streamlining the quality assessment in medication reviews: a biased random sampling approach using BRANT-MERQS

Eline Tobback1, Maja Brumer1, Anneleen Robberechts1,2

  • 1Laboratory of Physiopharmacology, University of Antwerp, Antwerp, Belgium.

Abstract

Insights

A streamlined Medication Review type 3 (MR3) quality assessment was developed. A 10-criteria biased subsample of the BRANT-MERQS tool provides reliable and efficient quality scoring for patient treatment optimization.

Area of Science:

  • Clinical Pharmacy
  • Quality Improvement
  • Medication Management

Background:

  • Medication Review type 3 (MR3) is a comprehensive clinical service for optimizing patient treatment.
  • The BRussels ANTwerp Medication Review Quality score (BRANT-MERQS) assesses MR3 quality using 49 criteria.
  • Current assessment methods are laborious and time-intensive, requiring a more efficient approach.

Purpose of the Study:

  • To develop a reliable and more efficient scoring system for evaluating MR3 quality.
  • To streamline the assessment process while maintaining accuracy.

Main Methods:

  • A random, weighted subset of BRANT-MERQS criteria was used in repeated testing.
  • Weighting was based on the pre-assessed importance of each criterion.
  • Determined the necessary subsample size for accurate quality scores.

Main Results:

  • A 10-criteria random subsample reliably yielded accurate MR3 quality scores.
  • A biased sampling approach (5-3-1 ratio) demonstrated improvements over unbiased sampling.
  • The optimized subset represents one-third of the full assessment.

Conclusions:

  • A more efficient MR3 quality evaluation tool was developed using a subset of the BRANT-MERQS criteria.
  • The 10-criteria biased subsample ensures both time efficiency and consistency in quality assessment.
  • This method optimizes patient treatment through effective medication review.

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
732
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
420
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.2K
Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.3K
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
874
Assessment of blood pressure in brachial artery(one-step method)01:15

Assessment of blood pressure in brachial artery(one-step method)

This procedural guide systematically measures blood pressure using an oscillometric digital sphygmomanometer, emphasizing accuracy, patient safety, and comfort.
Prepare for the Procedure:
544